(Q53544143)

English

Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome. (English)

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

stem cell transplantation

1 reference

based on heuristic

inferred from title

Paolo Corradini

1

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

2

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

3

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

6

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

Cristiana Carniti

14

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

Francesca Bonifazi

17

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

author name string

R Fanin

4

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

F Patriarca

5

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

P Matteucci

7

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

M Bregni

8

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

R Scimè

9

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

F Narni

10

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

E Pogliani

11

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

A Locasciulli

12

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

R Milani

13

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

A Bacigalupo

15

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

A Rambaldi

16

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

A Olivieri

18

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

A M Gianni

19

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

C Tarella

20

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

Gruppo Italiano Trapianto di Midollo Osseo

21

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

publication date

28 June 2007

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

21

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

11

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

2316-2323

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404822

0 references

Factors associated with survival in patients with progressive disease following autologous transplant for lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404822

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404822

7 January 2021

based on heuristic

inferred from DOI database lookup

Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404822

7 January 2021

based on heuristic

inferred from DOI database lookup

An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404822

7 January 2021

based on heuristic

inferred from DOI database lookup

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404822

7 January 2021

based on heuristic

inferred from DOI database lookup

Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404822

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404822

7 January 2021

based on heuristic

inferred from DOI database lookup

BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404822

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404822

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404822

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404822

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404822

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-Term Follow-Up of Indolent Lymphoma Patients Treated With High-Dose Sequential Chemotherapy and Autografting: Evidence That Durable Molecular and Clinical Remission Frequently Can Be Attained Only in Follicular Subtypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404822

7 January 2021

based on heuristic

inferred from DOI database lookup

Flexible regression models with cubic splines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404822

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404822

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404822

7 January 2021

based on heuristic

inferred from DOI database lookup

Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404822

7 January 2021

based on heuristic

inferred from DOI database lookup

Myeloablative allogeneic hematopoietic stem cell transplantation for non-Hodgkin lymphoma: a nationwide survey in Japan.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404822

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404822

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404822

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404822

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404822

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404822

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404822

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune-mediated attack in relapsed Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404822

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404822

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2404822

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

1 reference

Europe PubMed Central

15 May 2018

http://europepmc.org/abstract/MED/17597807

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53544143&oldid=1973787012"